THE USE OF PROSTATE-SPECIFIC ANTIGEN AND FREE/TOTAL PROSTATE-SPECIFIC ANTIGEN IN THE DIAGNOSIS OF LOCALIZED PROSTATE CANCER
Open Access
- 1 November 1996
- journal article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 23 (4) , 531-540
- https://doi.org/10.1016/s0094-0143(05)70333-5
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and RatiosJournal of Urology, 1995
- In vivo and in vitro complex formation of prostate specific antigen with αi‐anti‐chymotrypsinThe Prostate, 1995
- Clinical usefulness of free and complexed PSAScandinavian Journal of Clinical and Laboratory Investigation, 1995
- Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancerThe Lancet, 1994
- Complex formation between protein C inhibitor and prostate‐specific antigen in vitro and in human semenEuropean Journal of Biochemistry, 1994
- Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system.Journal of Clinical Investigation, 1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Enzymatic activity of prostate‐specific antigen and its reactions with extracellular serine proteinase inhibitorsEuropean Journal of Biochemistry, 1990
- Prostate Specific Antigen—a Screening Test for Prostatic Cancer?British Journal of Urology, 1989
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987